Agilent Technologies (NYSE:A – Get Free Report) will be posting its quarterly earnings results after the market closes on Wednesday, August 21st. Analysts expect Agilent Technologies to post earnings of $1.29 per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.
Agilent Technologies (NYSE:A – Get Free Report) last released its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.03. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The firm had revenue of $1.57 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the previous year, the firm earned $1.27 earnings per share. The firm’s revenue was down 8.4% on a year-over-year basis. On average, analysts expect Agilent Technologies to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.
Agilent Technologies Price Performance
A stock opened at $140.52 on Tuesday. The firm has a 50 day moving average of $133.47 and a 200-day moving average of $138.42. The company has a market cap of $41.00 billion, a price-to-earnings ratio of 33.22, a PEG ratio of 4.86 and a beta of 1.05. The company has a current ratio of 2.15, a quick ratio of 1.64 and a debt-to-equity ratio of 0.34. Agilent Technologies has a 12-month low of $96.80 and a 12-month high of $155.35.
Agilent Technologies Announces Dividend
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on A shares. Wolfe Research lowered shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research report on Thursday, June 27th. Stifel Nicolaus dropped their price objective on shares of Agilent Technologies from $163.00 to $151.00 and set a “buy” rating for the company in a research note on Thursday, May 30th. UBS Group reduced their target price on Agilent Technologies from $155.00 to $141.00 and set a “neutral” rating on the stock in a research note on Thursday, May 30th. Evercore ISI raised their price target on Agilent Technologies from $126.00 to $130.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 2nd. Finally, Bank of America increased their price objective on Agilent Technologies from $134.00 to $140.00 and gave the company a “neutral” rating in a research note on Tuesday, June 25th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $137.27.
Read Our Latest Stock Report on Agilent Technologies
Insider Buying and Selling
In related news, SVP Dominique Grau sold 15,000 shares of the firm’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the completion of the sale, the senior vice president now directly owns 49,486 shares of the company’s stock, valued at approximately $6,595,494.08. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of the stock in a transaction on Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the transaction, the senior vice president now directly owns 49,486 shares in the company, valued at approximately $6,595,494.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction dated Friday, July 26th. The stock was sold at an average price of $140.00, for a total transaction of $274,120.00. Following the completion of the sale, the chief executive officer now directly owns 26,076 shares of the company’s stock, valued at approximately $3,650,640. The disclosure for this sale can be found here. In the last three months, insiders sold 18,916 shares of company stock valued at $2,527,860. Company insiders own 0.33% of the company’s stock.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Stories
- Five stocks we like better than Agilent Technologies
- Manufacturing Stocks Investing
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- EV Stocks and How to Profit from Them
- 2 Option Strategies to Maximize Profits in a Bear Market
- Compound Interest and Why It Matters When Investing
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.